Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patientsJ L Westra, H Hollema, M Schaapveld, et al.Genes, Chromosomes & Cancer|September 8, 2006
Functional analysis of lung tumor suppressor activity at 3p21.3Arja ter Elst, Bea E Hiemstra, Pieter van der Vlies, et al.American Journal of Medical Genetics. Part A|October 13, 2006
FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletionsTrijnie Dijkhuizen, Ton van Essen, Pieter van der Vlies, et al.European Journal of Medical Genetics|September 24, 2005
Application of a comprehensive subtelomere array in clinical diagnosis of mental retardationKlaas Kok, Trijnie Dijkhuizen, Yolanthe E Swart, et al.Genes, Chromosomes & Cancer|February 25, 2005
A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instabilityJantine L Westra, Ludolf G Boven, Pieter van der Vlies, et al.Cancer Genetics and Cytogenetics|September 23, 2003
RFP2, c13ORF1, and FAM10A4 are the most likely tumor suppressor gene candidates for B-cell chronic lymphocytic leukemiaW J van Everdink, A Baranova, C Lummen, et al.American Journal of Human Genetics|March 11, 2005
Identifying candidate Hirschsprung disease-associated RET variantsGrzegorz M Burzynski, Ilja M Nolte, Agnes Bronda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patientsJantine L Westra, Michael Schaapveld, Harry Hollema, et al.Cancer Research|March 9, 2005
RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factorIvan Plaza Menacho, Roelof Koster, Almer M van der Sloot, et al.Human Mutation|December 26, 2003
DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patientsRobert M W Hofstra, Inge M Mulder, Rolf Vossen, et al.Pageof 4